BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 8:35:47 AM | Browse: 389 | Download: 1104
 |
Received |
|
2020-12-02 22:36 |
|
Peer-Review Started |
|
2020-12-02 22:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-31 15:11 |
|
Revised |
|
2020-12-31 17:59 |
|
Second Decision |
|
2021-02-23 06:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-02-24 06:01 |
|
Articles in Press |
|
2021-02-24 06:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-01 02:31 |
|
Typeset the Manuscript |
|
2021-04-26 08:23 |
|
Publish the Manuscript Online |
|
2021-04-29 08:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Case Report |
| Article Title |
Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Alberto Meyer, Bárbara J Carvalho, Kayo AA Medeiros, Leonardo Z Pipek, Fernanda S Nascimento, Milena O Suzuki, João VT Munhoz, Leandro R Iuamoto, Luiz A Carneiro-D'Alburquerque and Wellington Andraus |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alberto Meyer, FACS, MD, MSc, PhD, Assistant Professor, Gastroenterologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av Dr Arnaldo 455, São Paulo 01426-010, Brazil. alberto.meyer@usp.br |
| Key Words |
Neoadjuvant chemotherapy; Pancreatic cancer; Resectable pancreatic cancer; Borderline resectable; Neoadjuvant; Pancreas |
| Core Tip |
Neoadjuvant treatment with folinic acid, 5-FU, irinotecan and oxaliplatine or gemcitabine plus nab-paclitaxel has become a standard of care for borderline or locally advanced pancreatic cancer and is increasingly considered even for up-front resectable disease. |
| Publish Date |
2021-04-29 08:35 |
| Citation |
Meyer A, Carvalho BJ, Medeiros KA, Pipek LZ, Nascimento F, Suzuki M, Munhoz J, Iuamoto LR, Carneiro-D'Alburquerque LA, Andraus W. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report. World J Clin Cases 2021; 9(14): 3418-3423 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i14/3418.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i14.3418 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
